Amgen 2001 Annual Report Download - page 35

Download and view the complete annual report

Please find page 35 of the 2001 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 54

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54

AMGEN 2001 ANNUAL REPORT
December 31, 2001 2000
Assets
Current assets:
Cash and cash equivalents $ 689.1 $ 226.5
Marketable securities 1,973.1 1,801.6
Trade receivables, net of allowance for doubtful accounts of
$21.4 in 2001 and $21.2 in 2000 497.2 389.2
Inventories 355.6 305.2
Other current assets 343.6 214.6
Total current assets 3,858.6 2,937.1
Property, plant, and equipment at cost, net 1,946.1 1,781.5
Other assets 638.4 681.0
$6,443.1 $5,399.6
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable $ 136.7 $ 143.2
Commercial paper 99.9 99.7
Accrued liabilities 766.3 619.2
Total current liabilities 1,002.9 862.1
Long-term debt 223.0 223.0
Stockholders’ equity:
Preferred stock; $0.0001 par value; 5.0 shares authorized;
none issued or outstanding ——
Common stock and additional paid-in capital; $0.0001 par
value; 2,750.0 shares authorized; outstanding – 1,045.8
shares in 2001 and 1,037.4 shares in 2000 3,474.1 2,947.3
Retained earnings 1,686.8 1,304.6
Accumulated other comprehensive income 56.3 62.6
Total stockholders’ equity 5,217.2 4,314.5
$6,443.1 $5,399.6
See accompanying notes.
Consolidated Balance Sheets
(In millions, except per share data)
33